Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MP0250 |
Trade Name | |
Synonyms | MP-0250 |
Drug Descriptions |
MP0250 is a protein therapeutic that targets VEGFA, HGF, and human serum albumin, resulting in decreased downstream signaling and reduced angiogenesis, and potentially leading to decreased tumor growth (PMID: 29568363, PMID: 29228696). |
DrugClasses | |
CAS Registry Number | 1816305-70-0 |
NCIT ID | C117236 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MP0250 | MP0250 | 0 | 1 |